Altogether, our findings suggest that upregulated expression of FOXM1 impairs CMA by suppressing the transcription of LAMP2A; CMA impairment enhances ER stress, which in turn increases FOXM1 expression and FC levels, resulting in a vicious cycle and promoting the development of NASH. Here, FOXM1 is linked to metabolic dysfunction-associated steatohepatitis.